In this issue:
Changes in early mortality and outcomes in older MM patients
Prognostic index for MM treated with front-line autologous SCT
Three different bortezomibbased regimens for previously untreated MM
Clinical features, outcomes and prognostic factors of solitary plasmacytomas
Prognostic value of deep sequencing for MRD detection in MM
MRI bone marrow pattern for predicting MM progression after autologous SCT
Single-agent anti-MM drugs in phase I/II trials
High-dose chemotherapy + repeat SCT in MM relapsed after initial SCT
CCyd in newly diagnosed MM
Please login below to download this issue (PDF)